Conference Highlights

10 Key Reasons to Join Us This February

  1. Promote the Awareness and Understanding of Personalised & Precision Medicine among Key Leaders in the Healthcare Ecosystem
  2. Redefine Healthcare Delivery by Integrating and Expanding Personalised & Precision Medicine into Clinical Practice
  3. Encourage the Uptake of Precision Medicine by Overcoming Funding Challenges, Talent Shortages and Regulatory Restrictions
  4. Catalyze the Effort in Building Up a Genetic Database with State-of-the-art Technologies (Big Data & AI)
  5. Increase Collaboration between Public and Private Healthcare Sector in Driving Novel Targeted Medical Intervention
  6. Strengthen Efforts in Accelerating the Development of Precision Medicine Treating Diseases from Cancer to Diabetes
  7. Improve the Overall Healthcare Industry with Discovery and Identification of Human Genome
  8. Obtain Exclusive Insights from a wide range of Discussions in Paving the Way for Precision Medicine
  9. Nurture Healthcare Professionals of the Next Generation by Equipping them with the Skills & Knowledge on how to Navigate in the Age of Personalised & Precision Medicine
  10. Seize and Secure Mutually Beneficial Partnerships with Academic & Industry Practitioners in both Public & Private Sectors through Exclusive Networking Sessions

Hot Topics to be Discussed

DAY 1: WEDNESDAY, 7 FEBRUARY 2017

  • Keynote Session: Impact of Precision Medicine on Healthcare
  • How do we Implement Precision Medicine in the Real World?
  • How Primary Care Doctors can Integrate Precision Medicine
    into their Clinical Practice?
  • Enabling Precision Medicine with Big Data
  • How AI and Machine Learning is Driving Precision Medicine &
    Genomic Findings
  • Breakthrough in Precision Medicine: Liquid Biopsy
  • Overcoming Skills Shortages and Talent Recruitment within the
    Precision Medicine industry

DAY 2: THURSDAY, 8 FEBRUARY 2017

  • Keynote Session: Applying Precision Medicine Outside of Cancer
  • Integrating Precision Medicine into Early Clinical Development
  • Pharmacogenomics in Clinical Practice: Conduits and Barriers
    to Implementation and Utilisation
  • Applying Precision Medicine in Cancer Treatment – Cancer
    Genomics
  • Improving Public-Private Partnership to Advance Precision
    Medicine with Better Affordability & Funding
  • The Economics of Bringing Precision Medicine into the
    Healthcare Arena

WORKSHOPS: FRIDAY, 9 FEBRUARY 2018

  • Workshop A: Capitalize on the Precision Medicine Wave –
    Creating a Sustainable & Scalable Bio-Tech Business
  • Workshop B: Effective Fundraising Strategies to Drive
    Precision Medicine Initiatives

Companies Expected at the Conference

  • Abbott
  • Aslan Pharmaceuticals
  • Astella Pharma
  • AstraZeneca
  • GE HealthCare
  • GSK: GlexoSmithKline
  • Janssen Research & Development
  • MSD
  • Novartis
  • Takeda
  • Sanofi
  • Thermo Fisher Scientifc
  • Yong Loo Lin School of Medicine, NUS
  • Duke-NUS Medical School
  • Lee Kong Chian School of Medicine
  • Parkway College
  • Ngee Ann Polytechnic
  • Nanyang Polytechnic
  • NTU Singapore
  • National University Health System (NUHS)
  • Alexandra Health
  • SingHealth
  • Ng Teng Fong Hospital
  • John Hopkins Singapore International Medical Centre
  • National Cancer Centre Singapore
  • iDNA
  • Liftstream
  • PSC Biotech Pte Ltd
  • Advent Biotech Pte Ltd
  • AIM Biotech Pte Ltd